Rossetti Andrea C, Papp Mariusz, Gruca Piotr, Paladini Maria Serena, Racagni Giorgio, Riva Marco A, Molteni Raffaella
Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy.
Institute of Pharmacology, Polish Academy of Sciences, Kracow, Poland.
Pharmacol Res. 2016 Jan;103:1-12. doi: 10.1016/j.phrs.2015.10.022. Epub 2015 Nov 1.
Major depression is a complex disease that originates from the interaction between a genetic background of susceptibility and environmental factors such as stress. At molecular level, it is characterized by dysfunctions of multiple systems including neurotransmitters, hormones, signalling pathways, neurotrophic and neuroplastic molecules and - more recently - inflammatory mediators. Accordingly, in the present study we used the chronic mild stress (CMS) paradigm in the rat to elucidate to what extent brain inflammation may contribute to the development and/or the maintenance of an anhedonic phenotype and how pharmacological intervention may interfere with such behavioral and molecular stress-induced alterations. To this aim, adult male rats were exposed to CMS for 2 weeks and the cerebral expression of several mediators of the inflammatory system was evaluated in the hippocampus and prefrontal cortex of both stressed and control animals in parallel with the sucrose intake. Next, the animals that showed a decreased sucrose consumption were exposed to five further weeks of CMS and treated with the antidepressants imipramine or agomelatine, or the antipsychotic lurasidone. Our results demonstrate that only the stressed animals that were characterized by a deficit in sucrose intake showed increased expression of the pro-inflammatory cytokines IL-1β, IL-6 and up-regulation of markers and mediators of microglia activation such as CD11b, CX3CL1 and its receptor CX3CR1 in comparison with stress-resilient animals. Some of these molecular alterations persisted also after longer stress exposure and were modulated, similarly to the behavioral effects of CMS, by chronic pharmacological treatment. These data suggest that neuroinflammation may have a key role in the pathological consequences of stress exposure, thus contributing to the subject's vulnerability for depression.
重度抑郁症是一种复杂的疾病,源于易感性遗传背景与压力等环境因素之间的相互作用。在分子水平上,其特征是多个系统功能失调,包括神经递质、激素、信号通路、神经营养和神经可塑性分子,以及最近发现的炎症介质。因此,在本研究中,我们使用大鼠慢性轻度应激(CMS)模型,以阐明脑部炎症在多大程度上可能导致快感缺失表型的发展和/或维持,以及药物干预如何影响这种由应激诱导的行为和分子改变。为此,成年雄性大鼠接受2周的CMS处理,同时评估应激组和对照组动物海马体和前额叶皮质中几种炎症系统介质的脑内表达,并测量其蔗糖摄入量。接下来,将蔗糖消耗减少的动物再接受5周的CMS处理,并用抗抑郁药丙咪嗪或阿戈美拉汀,或抗精神病药鲁拉西酮进行治疗。我们的结果表明,与应激适应能力强的动物相比,只有那些表现出蔗糖摄入不足的应激动物,其促炎细胞因子IL-1β、IL-6的表达增加,小胶质细胞激活标志物和介质如CD11b、CX3CL1及其受体CX3CR1上调。其中一些分子改变在更长时间的应激暴露后仍然存在,并且与CMS的行为效应类似,可通过长期药物治疗进行调节。这些数据表明,神经炎症可能在应激暴露的病理后果中起关键作用,从而导致个体易患抑郁症。